Deka Bank Deutsche Girozentrale Sarepta Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

$53.9 Billion
Q3 2024

A detailed history of Deka Bank Deutsche Girozentrale transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Deka Bank Deutsche Girozentrale holds 30,945 shares of SRPT stock, worth $4.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

30,945

Previous 30,945 -0.0%

Holding current value

$4.04 Million

Previous $4.88 Million 21.43%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $96,862 - $116,792	945 Added 3.15%	30,945 $3.82 Million
Q2 2023 Jul 25, 2023	SELL	$106.4 - $157.19 $990,584 - $1.46 Million	-9,310 Reduced 23.68%	30,000 $3.37 Million
Q1 2023 Apr 24, 2023	BUY	$117.53 - $155.99 $158,665 - $210,586	1,350 Added 3.56%	39,310 $5.31 Million
Q1 2022 Apr 28, 2022	SELL	$63.15 - $90.42 $44,205 - $63,294	-700 Reduced 1.81%	37,960 $2.98 Million
Q4 2021 Feb 02, 2022	BUY	$77.28 - $99.42 $77,280 - $99,420	1,000 Added 2.66%	38,660 $3.51 Million
Q3 2021 Oct 22, 2021	SELL	$65.97 - $92.48 $1.35 Million - $1.9 Million	-20,500 Reduced 35.25%	37,660 $3.33 Million
Q2 2021 Aug 05, 2021	BUY	$69.38 - $86.75 $1.26 Million - $1.58 Million	18,170 Added 45.44%	58,160 $4.55 Million
Q1 2021 Apr 28, 2021	BUY	$72.25 - $168.95 $182,648 - $427,105	2,528 Added 6.75%	39,990 $2.91 Million
Q4 2020 Mar 12, 2021	SELL	$125.56 - $178.74 $169,380 - $241,120	-1,349 Reduced 3.48%	37,462 $6.42 Million
Q3 2020 Oct 29, 2020	BUY	$127.12 - $172.34 $4.37 Million - $5.93 Million	34,381 Added 776.09%	38,811 $5.51 Million
Q2 2020 Aug 04, 2020	SELL	$93.0 - $171.7 $11,532 - $21,290	-124 Reduced 2.72%	4,430 $717,000
Q1 2020 May 14, 2020	SELL	$82.38 - $131.64 $131,725 - $210,492	-1,599 Reduced 25.99%	4,554 $441,000
Q4 2019 Feb 04, 2020	SELL	$76.53 - $135.58 $2.84 Million - $5.03 Million	-37,089 Reduced 85.77%	6,153 $795,000
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $2.33 Million - $5.01 Million	-31,938 Reduced 42.48%	43,242 $3.26 Million
Q2 2019 Aug 01, 2019	BUY	$112.21 - $151.95 $5.07 Million - $6.86 Million	45,149 Added 150.34%	75,180 $9.76 Million
Q1 2019 May 10, 2019	BUY	$106.67 - $151.68 $408,119 - $580,327	3,826 Added 14.6%	30,031 $4.2 Million
Q4 2018 Feb 12, 2019	SELL	$97.32 - $148.76 $372,346 - $569,155	-3,826 Reduced 12.74%	26,205 $2.82 Million
Q3 2018 Nov 09, 2018	BUY	$115.31 - $161.51 $372,566 - $521,838	3,231 Added 12.06%	30,031 $0
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $186,524 - $399,594	-2,600 Reduced 8.84%	26,800 $3.59 Million
Q1 2018 May 03, 2018	BUY	$54.02 - $82.27 $252,111 - $383,954	4,667 Added 18.87%	29,400 $2.11 Million
Q3 2017 Nov 06, 2017	BUY	$35.73 - $47.15 $883,710 - $1.17 Million	24,733	24,733 $926,000

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Account

Deka Bank Deutsche Girozentrale Sarepta Therapeutics, Inc. Transaction History